Vaccine News and Research

Latest Vaccine News and Research

MAIT cells of immune system can fight all sorts of bacterial and viral infections

Oxford University research has found that a little-studied and relatively unknown part of the human immune system could be twice as important as previously thought.

23 Jun 2016

Major review highlights lack of genetic understanding of Zika virus

A major review of the Zika virus has concluded that further research to understand the nature of the virus is critical to developing antiviral treatments and vaccines.The paper, published in the journal Veterinary Quarterly, considers the breadth of current research and highlights a lack of understanding of the nature of the virus.

23 Jun 2016

Inflammatory response to mosquito bites can help spread viral infections

Mosquito bite sites are not just itchy, irritating nuisances - they also make viral infections spread by the insects far worse, new research has found.

22 Jun 2016

VUMC researchers aim to decode genetic underpinnings of human immune system

Researchers at Vanderbilt University Medical Center this month began recruiting volunteers to participate in a clinical trial aimed at decoding the human "immunome," the genetic underpinnings of the immune system.

22 Jun 2016

Unmanned drones could be economical to deliver vaccines quickly in developing countries

Using unmanned drones to deliver vaccines in low- and middle-income countries may save money and improve vaccination rates, new research led by the Johns Hopkins Bloomberg School of Public Health and the Pittsburgh Supercomputing Center suggests.

21 Jun 2016

Researchers aim to improve medical treatment for people with insect venom allergy

A team of researchers has elucidated individual profiles of allergy reactivity in patients that are not protected after treatment with immunotherapy. The aim is to improve medical treatment of people who are allergic to insect stings.

21 Jun 2016

E-cigarette use modifies gene expression important for upper airway immune defense

When we smoke cigarettes, dozens of genes important for immune defense are altered in the epithelial cells that line the respiratory tract. Several of these changes likely increase the risk of bacterial infections, viruses, and inflammation.

21 Jun 2016

Fractional dosing approach could be used to control yellow fever outbreaks during vaccine shortages

The yellow fever vaccine given as one fifth of the regular dose could be used to control an outbreak in case of vaccine shortages.

20 Jun 2016

Revised Zika Strategic Response Plan focuses on preventing, managing medical complications

The World Health Organization (WHO)/the Pan American Health Organization (PAHO) and partners have set out their strategic response to Zika which will place a greater focus on preventing and managing medical complications caused by Zika virus infection.

20 Jun 2016

RVFV uses cancer pathway to hijack host cell and cause infection

Viruses can't live without us -- literally. As obligate parasites, viruses need a host cell to survive and grow. Scientists are exploiting this characteristic by developing therapeutics that close off pathways necessary for viral infection, essentially stopping pathogens in their tracks.

17 Jun 2016

WHO convenes Emergency Committee's 3rd meeting to discuss on Zika virus and associated complications

On 14 June 2016, the World Health Organization will convene the 3rd meeting of the Emergency Committee under the International Health Regulations (2005) (IHR) on Zika and observed increase in neurological disorders and neonatal malformations.

16 Jun 2016

Zika protection whilst traveling: an interview with Dr Crystal Aguh

The majority of the countries that are affected by the Zika virus are in the Caribbean. Many of the Caribbean Islands, including large islands such as Jamaica, Dominican Republic, Barbados and US Virgin Islands, as well as Mexico and other countries in Central and South America are affected.

16 Jun 2016

Emergence of multidrug-resistant salmonella strains increases burden of neglected diseases in Africa

"The affected countries will have a major problem if we do not manage to control salmonella bloodstream infections with new antibiotics such as ciprofloxacin," cautions Prof Jürgen May.

15 Jun 2016

How can we defeat drug resistance? An interview with Dr Grania Brigden

The O’Neill report is a wide ranging report recognising anti-microbial resistance (AMR) as a global problem with major public health and economic significance.

15 Jun 2016

Veterinarian conducts clinical trials to improve cancer treatment for animals, humans

Raelene Wouda's passion for improving cancer treatment starts with our four-legged friends.

15 Jun 2016

Topical delivery of AVR drug combination can provide complete protection against HIV

Researchers are edging ever closer to discovering the perfect combination of drugs and drug delivery system that will stop the sexual transmission of HIV.

14 Jun 2016

T memory cells with naive phenotype can help boost immunity in older adults

Sixty-five is the age when many people retire, kick back and take it easy. And so it often is with the human immune system.

14 Jun 2016

Study opens up new strategy to make immunotherapy more effective for different cancer types

By combining local radiation therapy and anti-cancer vaccines with checkpoint inhibitors, researchers from the University of Chicago, working with mice, were able to increase the response rate for these new immunotherapy agents.

14 Jun 2016

FDA approves Vaxchora for prevention of cholera

The U.S. Food and Drug Administration today approved Vaxchora, a vaccine for the prevention of cholera caused by serogroup O1 in adults 18 through 64 years of age traveling to cholera-affected areas. Vaxchora is the only FDA-approved vaccine for the prevention of cholera.

13 Jun 2016

New vaccine found safe, effective against Toxic Shock Syndrome

Toxic Shock Syndrome (TSS) is a severe circulatory and organ failure caused by bacterial toxins, usually triggered by bacteria from the Staphylococcus group. Researchers from MedUni Vienna's Department of Clinical Pharmacology, in collaboration with the company Biomedizinische Forschungsgesellschaft mbH in Vienna, have now developed the world's first safe and effective vaccine against this disease and successfully tested it in a Phase I trial.

13 Jun 2016

Vaccine News and Research

Latest Vaccine News and Research

MAIT cells of immune system can fight all sorts of bacterial and viral infections

Major review highlights lack of genetic understanding of Zika virus

Inflammatory response to mosquito bites can help spread viral infections

VUMC researchers aim to decode genetic underpinnings of human immune system

Unmanned drones could be economical to deliver vaccines quickly in developing countries

Researchers aim to improve medical treatment for people with insect venom allergy

E-cigarette use modifies gene expression important for upper airway immune defense

Fractional dosing approach could be used to control yellow fever outbreaks during vaccine shortages

Revised Zika Strategic Response Plan focuses on preventing, managing medical complications

RVFV uses cancer pathway to hijack host cell and cause infection

WHO convenes Emergency Committee's 3rd meeting to discuss on Zika virus and associated complications

Zika protection whilst traveling: an interview with Dr Crystal Aguh

Emergence of multidrug-resistant salmonella strains increases burden of neglected diseases in Africa

How can we defeat drug resistance? An interview with Dr Grania Brigden

Veterinarian conducts clinical trials to improve cancer treatment for animals, humans

Topical delivery of AVR drug combination can provide complete protection against HIV

T memory cells with naive phenotype can help boost immunity in older adults

Study opens up new strategy to make immunotherapy more effective for different cancer types

FDA approves Vaxchora for prevention of cholera

New vaccine found safe, effective against Toxic Shock Syndrome

Event guide: 3rd mRNA Process Development & Manufacturing Europe eBook

Unlocking drug amorphization: Continuous, solvent-free twin screw granulation

How can super-resolution technology help study neurotransmission?

The Proteoform Puzzle: Unlocking the Next Frontier

Vaccine News and Research

Latest Vaccine News and Research

Event guide: 3rd mRNA Process Development & Manufacturing Europe eBook

Unlocking drug amorphization: Continuous, solvent-free twin screw granulation

How can super-resolution technology help study neurotransmission?

The Proteoform Puzzle: Unlocking the Next Frontier

Newsletters you may be interested in